Charles River Laboratories (CRL) – Super Equities Snapshot
Date: August 28, 2025
Ticker: CRL
Summary Outlook: Our Super Equities models identify CRL as a high-potential opportunity, with the most likely upcoming bottom coming up between January–March 2026, aligning with the projected broad market bottom.
Timing & Price
-
Bottom Window:
-
Most probable: Jan–Mar 2026. We have a powerful cycle cluster arriving in January/February and a cycle composite bottoming in March.
-
Prior clusters in Sept 2025, but dominant cycles point further out
-
-
Price Target:
-
Target entry: Most likely bottom completion point is located at $70 (+/- $5)
-
Upside Potential
If the 2026 bottom is confirmed, CRL could rally to $600–$800/share over the next cycle—a potential 8–10x move from the optimal entry range. The next major cycle high arrives in mid 2027.
Action Plan
-
Wait for confirmation of a final bottom, ideally in early 2026
-
No buy triggers at current levels; avoid chasing the rebound
In summary: We expect CRL to bottom in early 2026 at $70 (+/- $5). Once the bottom is in we expect the stock to increase as much as 6-8X by mid 2027. Begin targeting analysis as soon as the stock breaks below recent prior low of $90.
